Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review
Cancers · 14.10.2023 · 15 (20) · 4987
DOI: 10.3390/cancers15204987 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 14.10.2023. Verfasst von Masoud Bitaraf und 2 weiteren Autor:innen. Beteiligte Einrichtung: Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran 1419733141, Iran. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diagnosis and risk stratification are cornerstones of therapeutic decisions in the management of patients with upper tract urothelial carcinoma (UTUC). Diagnostic modalities provide data that can be integrated, to provide nomograms and stratification tools to predict survival and adverse outcomes. This study reviews cytology, ureterorenoscopy and the novel tools and techniques used with it (including photodynamic diagnosis, narrow-band imaging, optical coherence tomography, and confocal laser endomicroscopy), and biopsy. Imaging modalities and novel biomarkers are discussed in another article. Patient- and tumor-related prognostic factors, their association with survival indices, and their roles in different scores and predictive tools are discussed. Patient-related factors include age, sex, ethnicity, tobacco consumption, surgical delay, sarcopenia, nutritional status, and several blood-based markers. Tumor-related prognosticators comprise stage, grade, presentation, location, multifocality, size, lymphovascular invasion, surgical margins, lymph node status, mutational landscape, architecture, histologic variants, and tumor-stroma ratio. The accuracy and validation of pre-operative predictive tools, which incorporate various prognosticators to predict the risk of muscle-invasive or non-organ confined disease, and help to decide on the surgery type (radical nephroureterectomy, or kidney-sparing procedures) are also investigated. Post-operative nomograms, which help decide on adjuvant chemotherapy and plan follow-up are explored. Finally, a revision of the current stratification of UTUC patients is endorsed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran 1419733141, Iran.
ORCID-Profile: Masoud Bitaraf, Mahmood Ghafoori Yazdi
Zitieren
APA
Bitaraf, M., Ghafoori Yazdi, M., & Amini, E. (2023). Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review. Cancers, 15(20), 4987. https://doi.org/10.3390/cancers15204987
Vancouver
Bitaraf M, Ghafoori Yazdi M, Amini E. Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review. Cancers. 2023;15(20):4987. doi:10.3390/cancers15204987
BibTeX
@article{Bitaraf2023,
author = {Bitaraf, Masoud and Ghafoori Yazdi, Mahmood and Amini, Erfan},
title = {Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review},
journal = {Cancers},
year = {2023},
volume = {15},
number = {20},
pages = {4987},
doi = {10.3390/cancers15204987}
}
EUVIMED